Davis Select U.S. Equity ETF (DUSA) Sets New 1-Year Low at $21.69

Davis Select U.S. Equity ETF (NASDAQ:DUSA)’s share price reached a new 52-week low during trading on Thursday . The company traded as low as $21.69 and last traded at $21.93, with a volume of 22310 shares traded. The stock had previously closed at $22.30.

Several large investors have recently added to or reduced their stakes in the company. Morgan Stanley lifted its holdings in shares of Davis Select U.S. Equity ETF by 10.9% during the 3rd quarter. Morgan Stanley now owns 423,687 shares of the healthcare company’s stock worth $10,707,000 after acquiring an additional 41,686 shares during the period. LPL Financial LLC lifted its holdings in shares of Davis Select U.S. Equity ETF by 8.1% during the 3rd quarter. LPL Financial LLC now owns 87,070 shares of the healthcare company’s stock worth $2,200,000 after acquiring an additional 6,536 shares during the period. D.A. Davidson & CO. lifted its holdings in shares of Davis Select U.S. Equity ETF by 11.7% during the 3rd quarter. D.A. Davidson & CO. now owns 50,675 shares of the healthcare company’s stock worth $1,281,000 after acquiring an additional 5,300 shares during the period. IFP Advisors Inc lifted its holdings in shares of Davis Select U.S. Equity ETF by 115.2% during the 3rd quarter. IFP Advisors Inc now owns 47,784 shares of the healthcare company’s stock worth $1,207,000 after acquiring an additional 25,578 shares during the period. Finally, Jane Street Group LLC bought a new position in shares of Davis Select U.S. Equity ETF during the 3rd quarter worth about $584,000.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/12/08/davis-select-u-s-equity-etf-dusa-sets-new-1-year-low-at-21-69.html.

About Davis Select U.S. Equity ETF (NASDAQ:DUSA)

DUSA Pharmaceuticals, Inc (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company’s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp.

Featured Article: How to Calculate Compound Annual Growth Rate (CAGR)

Receive News & Ratings for Davis Select U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davis Select U.S. Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply